Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2026-01-02 @ 3:54 PM
Study NCT ID:
NCT04221451
Status:
TERMINATED
Last Update Posted:
2024-12-30
First Post:
2020-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of Venglustat in Late-onset GM2
Sponsor:
Genzyme, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-29
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-26
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-06
First Submit QC Date:
None
Study First Post Date:
2020-01-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-26
Last Update Post Date:
2024-12-30
Last Update Post Date Type:
ACTUAL